New Zealand markets closed

Ventyx Biosciences, Inc. (VTYX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.8300+0.1000 (+2.11%)
At close: 04:00PM EDT
4.8400 +0.01 (+0.21%)
After hours: 07:41PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
174,077
175,767
87,738
58,481
6,366
Selling general and administrative
33,133
32,227
25,398
8,666
684
Total operating expenses
207,210
207,994
113,136
67,147
7,050
Operating income or loss
-207,210
-207,994
-113,136
-67,147
-7,050
Interest expense
-
-
0
99
358
Total other income/expenses net
-72
-42
41
-16,578
-20,766
Income before tax
-192,603
-192,962
-108,426
-83,746
-28,174
Income from continuing operations
-192,603
-192,962
-108,426
-83,746
-28,174
Net income
-192,603
-192,962
-108,426
-83,746
-28,174
Net income available to common shareholders
-192,603
-192,962
-108,426
-85,298
-28,174
Basic EPS
-3.15
-
-2.07
-6.65
-1.33
Diluted EPS
-3.15
-
-2.07
-6.65
-1.33
Basic average shares
57,965
-
52,471
12,826
21,120
Diluted average shares
57,965
-
52,471
12,826
21,120